Regeneron, Lily, and AstraZeneca are developing and trialing monoclonal antibodies. The hope is they will protect those who are immunocompromised and respond poorly to Covid vaccines.
Can’t wait!
Yuck
Regeneron, Lily, and AstraZeneca are developing and trialing monoclonal antibodies. The hope is they will protect those who are immunocompromised and respond poorly to Covid vaccines.
Can’t wait!
Yuck
That’s great news Yuck thank you.Ann
That's the hope.
When should the trials be finished?
🤞🤞🤞
That’s encouraging news!